Edition:
United Kingdom

Brainstorm Cell Therapeutics Inc (BCLI.OQ)

BCLI.OQ on NASDAQ Stock Exchange Capital Market

3.68USD
21 Aug 2019
Change (% chg)

$-0.02 (-0.54%)
Prev Close
$3.70
Open
$3.68
Day's High
$3.71
Day's Low
$3.64
Volume
17,715
Avg. Vol
20,207
52-wk High
$4.50
52-wk Low
$2.95

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Jun '19 0.00 -0.226
Mar '19 0.00 -0.240
FY 2018 Dec '18 0.00 -0.260
Sep '18 0.00 -0.153
Jun '18 0.00 -0.158
Mar '18 0.00 -0.121
FY 2017 Dec '17 0.00 0.015
Sep '17 0.00 -0.128
Jun '17 0.00 -0.056
Mar '17 0.00 -0.096
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Sep-19 1 0.00 0.00 0.00 1.50
Quarter Ending Dec-19 1 0.00 0.00 0.00 1.50
Year Ending Dec-19 1 0.00 0.00 0.00 6.00
Year Ending Dec-20 2 49.25 98.50 0.00 94.60
Earnings (per share)
Quarter Ending Sep-19 2 -0.19 -0.15 -0.23 -0.02
Quarter Ending Dec-19 2 -0.17 -0.17 -0.17 -0.03
Year Ending Dec-19 2 -0.71 -0.56 -0.87 -0.43
Year Ending Dec-20 2 -0.86 -0.85 -0.86 -0.08
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 69.38 32.67
P/E High - Last 5 Yrs. -- 147.67 47.29
P/E Low - Last 5 Yrs. -- 47.98 23.87
Beta 1.54 1.09 0.89
Price to Sales (TTM) -- 49.44 7.91
Price to Book (MRQ) 10.34 10.14 5.38
Price to Tangible Book (MRQ) 10.39 13.74 6.71
Price to Cash Flow (TTM) -- 55.94 24.37
% Owned Institutions 12.71 3.66 1.45

Dividends

  Company industry sector
Dividend Yield -- 0.12 1.35
Dividend Yield - 5 Year Avg -- 0.09 1.38
Dividend 5 Year Growth Rate -- 0.78 4.54
Payout Ratio(TTM) -- 7.01 40.24

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 205.61 12.23
Sales (TTM) vs TTM 1 Yr. Ago -- 49.06 7.74
Sales - 5 Yr. Growth Rate -- 22.80 10.88
EPS (MRQ) vs Qtr. 1 Yr. Ago -7.62 75.23 42.99
EPS (TTM) vs TTM 1 Yr. Ago 25.48 -- --
EPS - 5 Yr. Growth Rate -- 11.92 10.32
Capital Spending - 5 Yr. Growth Rate 16.50 9.20 14.84

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 2.23 2.21
Current Ratio (MRQ) 10.80 3.59 3.03
LT Debt to Equity (MRQ) 0.00 18.56 10.20
Total Debt to Equity (MRQ) 0.00 31.18 14.55
Interest Coverage (TTM) -- -44.60 29.80

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 56.08 52.23
Gross Margin - 5 Yr. Avg. -- 60.28 50.41
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -110.39 13.13
Operating Margin (TTM) -- -183.88 6.91
Operating Margin - 5 Yr. Avg. -- -126.83 8.93
Pre-Tax Margin (TTM) -- -174.58 6.12
Pre-Tax Margin - 5 Yr. Avg. -- -132.59 9.23
Net Profit Margin (TTM) -- -181.27 2.75
Net Profit Margin - 5 Yr. Avg. -- -136.96 5.60
Effective Tax Rate (TTM) -- 22.42 22.40
Effective Tax Rate - 5 Yr. Avg. -- 15.43 22.74

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 7,668,961 887,152,661
Net Income/Employee (TTM) -- 533,934 101,829,344
Receivable Turnover (TTM) -- 6.28 5.93
Inventory Turnover (TTM) -- 1.88 3.36
Asset Turnover (TTM) 0.00 0.32 0.94

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -47.79 6.41 11.17
Return on Assets - 5 Yr. Avg. -71.19 5.50 12.34
Return on Investment (TTM) -52.76 8.95 14.48
Return on Investment - 5 Yr. Avg. -91.15 6.81 16.02
Return on Equity (TTM) -52.76 10.09 15.78
Return on Equity - 5 Yr. Avg. -93.46 8.42 17.01
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 42.12 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Brainstorm Cell Therapeutics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -5.41 -8.67 23 99
13 Week -10.67 -15.02 32 95
26 Week 0.25 -7.37 54 97
52 Week 66.12 40.80 82 71
YTD 58.27 38.99 77 73
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 8.85%
# of Holders: 41
Total Shares Held: 1,994,660
3 Mo. Net Change: -475,958
# New Positions: 3
# Closed Positions: 3
# Increased Positions: 16
# Reduced Positions: 7
# Net Buyers: 9
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.